SEA Vision becomes a partner of the Marchesini Group

The Marchesini Group has signed a 48% acquisition of SEA Vision, a leading creator of vision and inspection systems used in quality control and drug counterfeiting

picture of

Breaking News

KWS BioTest acquired by Charles River Laboratories

KWS BioTest, a spinout company from the University of Bristol, has been acquired by US-based Charles River Laboratories, ...

Cressall announces global distribution deal with RS Components

Resistor manufacturer Cressall, has signed a new global distribution agreement with electronic and industrial ...

Cancer Research UK to invest £45 m in clinical trials

Cancer Research UK has announced that £45 million will be invested into its network of clinical trials units across the ...

Getting drug pricing right

The pharmaceutical sector has faced growing criticism in recent years for the high price of its medicinal products. In ...

Debiopharm continues fight against antibiotic resistance

Debiopharm Group invests in antibiotic development with the acquisition of a minority stake in ABAC Therapeutics

Horizon Discovery enters agreement with immuno-oncology company

Horizon Discovery Group, specialists in gene editing and gene modulation technologies, has entered into a non-exclusive ...

A look back at 2017 healthcare transactions

Last year, 2017, saw 2011 deals complete, with Q2 showing the strongest performance with 29.4%, followed by Q1 with 27. ...

Celgene set to become leader in CAR-T space

According to GlobalData, a data and analytics company, Celgeneís acquisition of Juno Therapeutics puts the company in a ...

PCI intends to acquire Pharmaceutical Packaging Professionals

In a move aimed at targeting Asia-Pacific growth, PCI Pharma Services plans to acquire Melbourne-based clinical ...

An alternate look at pharmaceutical world revenues and drug affordability

This article forms part of the CPhI 2017 Annual Report, which will be released during CPhI Worldwide in Frankfurt, ...

Value judgement

During the course of the past two decades, the relationship between pharmaceutical companies and their outsourcing ...

Merck is set to lead pharmaceutical licensing deals in 2018

GlobalData, a specialist data and analytics company, expects that 2018 is likely to be Merckís year in terms of ...

Digital skills and access to finance top two Industry 4.0 challenges

Without access to appropriate and sustainable third-party finance, manufacturers face a challenge to make the digital ...